Share This Link

Incorrect. Although checking the client's blood pressure is important, it is not the priority action when administering a beta-blocker.

Incorrect. Evaluating renal function is not directly related to the administration of a beta-blocker. However, renal function should be considered in the overall assessment of the client's health status.

Incorrect. Monitoring blood glucose levels is not directly related to the administration of a beta-blocker. This action is more relevant for clients with diabetes who are taking medications that can affect blood glucose levels.

Incorrect. A heart rate of 60 beats per minute is within the expected range for a client taking digoxin, as it is commonly used to control heart rate in certain cardiac conditions.

Incorrect. A systolic blood pressure of 100 mmHg may be within an acceptable range for a client with heart failure, depending on their baseline blood pressure and symptoms. It does not require immediate nursing intervention.

Incorrect. A digoxin level of 1.2 ng/mL is within the therapeutic range for digoxin. It does not require immediate nursing intervention.

Incorrect. Avoiding foods high in vitamin K is not necessary, but consistency in vitamin K intake is important.

Incorrect. Increasing intake of foods high in vitamin K can counteract the effects of warfarin and increase the risk of blood clots.

Incorrect. Consuming unlimited amounts of foods high in vitamin K can interfere with the anticoagulant effects of warfarin and lead to inconsistent therapeutic response.

Incorrect. Prothrombin time (PT) is used to monitor clients receiving warfarin therapy, not heparin.

Incorrect. International normalized ratio (INR) is also used to monitor clients receiving warfarin therapy, not heparin.

Incorrect. Platelet count is important to monitor for heparin-induced thrombocytopenia (HIT), a potential adverse effect of heparin therapy, but it does not directly assess the client's response to heparin therapy.

Incorrect. ACE inhibitors do not directly affect blood glucose levels, although they may indirectly influence glycemic control in clients with diabetes.

Incorrect. Serum creatinine levels should be monitored regularly in clients receiving ACE inhibitors, as these medications can affect renal function. However, assessing serum potassium levels is a higher priority in this scenario.

Incorrect. White blood cell count is not directly related to ACE inhibitor therapy and does not require prioritization in this case.

Incorrect. Taking statin medication with the evening meal can optimize its effectiveness, as cholesterol synthesis typically occurs during nighttime.

Incorrect. Grapefruit can interfere with the metabolism of certain statins, leading to increased levels of the medication in the body. Therefore, it is important to avoid consuming grapefruit while taking statins.

Incorrect. Reporting muscle pain or weakness is crucial because statins can cause muscle-related side effects, including myopathy and rhabdomyolysis. Prompt reporting allows for early intervention or adjustment of the medication if necessary.

Incorrect. Although monitoring respiratory rate is important, it is not the priority assessment when caring for a client receiving intravenous nitroglycerin.

Incorrect. Oxygen saturation should be monitored for clients receiving nitroglycerin, but it is not the priority assessment in this scenario.

Incorrect. Blood glucose levels are not directly affected by nitroglycerin and do not require prioritization in this case.